A highly potent CD73 biparatopic antibody blocks organization of the enzyme active site through dual mechanisms
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A highly potent CD73 biparatopic antibody blocks organization of the enzyme active site through dual mechanisms
Authors
Keywords
CD73, antibody engineering, enzyme mechanism, enzyme structure, structure-function, protein complex, aggregation, protein crosslinking
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 295, Issue 52, Pages 18379-18389
Publisher
Elsevier BV
Online
2020-10-30
DOI
10.1074/jbc.ra120.012395
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
- (2019) Ivan Perrot et al. Cell Reports
- An Exceptionally Potent Inhibitor of Human CD73
- (2019) Christine E. Bowman et al. BIOCHEMISTRY
- Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target
- (2018) Jiayin Yang et al. CURRENT MEDICINAL CHEMISTRY
- Targeting the CD73-adenosine axis in immuno-oncology
- (2018) David Allard et al. IMMUNOLOGY LETTERS
- Targeting adenosine for cancer immunotherapy
- (2018) Robert D. Leone et al. Journal for ImmunoTherapy of Cancer
- Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers
- (2018) Lisa Seitz et al. INVESTIGATIONAL NEW DRUGS
- CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells
- (2018) Kerstin Schütze et al. Frontiers in Immunology
- The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
- (2017) Bertrand Allard et al. IMMUNOLOGICAL REVIEWS
- Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases
- (2017) Dipti Vijayan et al. OncoImmunology
- Antibodies Targeting Closely Adjacent or Minimally Overlapping Epitopes Can Displace One Another
- (2017) Yasmina Noubia Abdiche et al. PLoS One
- A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
- (2016) John Y. Li et al. CANCER CELL
- CD73–adenosine: a next-generation target in immuno-oncology
- (2016) David Allard et al. Immunotherapy
- Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action
- (2016) James C. Geoghegan et al. mAbs
- Targeting CD73 in the tumor microenvironment with MEDI9447
- (2016) Carl M. Hay et al. OncoImmunology
- Novel affinity binders for neutralization of vascular endothelial growth factor (VEGF) signaling
- (2015) Filippa Fleetwood et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Controlled Fab-arm exchange for the generation of stable bispecific IgG1
- (2014) Aran F Labrijn et al. Nature Protocols
- How good are my data and what is the resolution?
- (2013) Philip R. Evans et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Anti-Human CD73 Monoclonal Antibody Inhibits Metastasis Formation in Human Breast Cancer by Inducing Clustering and Internalization of CD73 Expressed on the Surface of Cancer Cells
- (2013) M. G. Terp et al. JOURNAL OF IMMUNOLOGY
- Production of stable bispecific IgG1 by controlled Fab-arm exchange
- (2013) Michael J Gramer et al. mAbs
- Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
- (2013) A. F. Labrijn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding to the Extracellular Domain of HER2
- (2013) Christian Jost et al. STRUCTURE
- Collaboration gets the most out of software
- (2013) Andrew Morin et al. eLife
- Crystal Structure of a Soluble Form of Human CD73 with Ecto-5′-Nucleotidase Activity
- (2012) Dominic P. H. M. Heuts et al. CHEMBIOCHEM
- Crystal Structure of the Human Ecto-5′-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling
- (2012) Karen Knapp et al. STRUCTURE
- REFMAC5 for the refinement of macromolecular crystal structures
- (2011) Garib N. Murshudov et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Studies of the Extracellular ATP-Adenosine Pathway in Human Urinary Tract Epithelial Cells
- (2009) Camilla Mohlin et al. PHARMACOLOGY
- Exploring blocking assays using Octet, ProteOn, and Biacore biosensors
- (2008) Yasmina N. Abdiche et al. ANALYTICAL BIOCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now